Nezam H. Afdhal - Concepedia

Author

Nezam H. Afdhal

Beth Israel Deaconess Medical Center ORCID

Also Known As

Abro Ferreira, Afdhal, Nezam H., Bollekens, Jacques, David Acheson, Do, Son, Eliot Godofsky, Goldstein, David B., Goulis, Ioannis, McHutchison, John G., Muir, Andrew J.

556

Publications

34.6K

Citations

H-Index

193

Concepts

All Affiliations

Beth Israel Deaconess Medical Center Harvard University Gilead Sciences (United States)Johns Hopkins University Boston University

About

Nezam H. Afdhal is an author at Beth Israel Deaconess Medical Center specializing in medicine, hepatology, and hepatitis.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	53	114	12.6K
2	Health Sciences	14	16	1.1K
3	Natural Sciences	5	5	151
4	Engineering	2	2	104
5	Education	1	1	25

Nezam H. Afdhal

227

Publications

29.1K

Citations

H-Index

Page 1

	Year	Citations
Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: a 5-year open-label follow-up study Patrick Marcellin, Edward Gane, Nezam H. Afdhal, The Lancet HepatologyViral HepatitisLiver PhysiologyMedicineHepatitis B	2012	1.7K
Ledipasvir and Sofosbuvir for Untreated HCV Genotype 1 Infection Nezam H. Afdhal, Stefan Zeuzem, Paul Y. Kwo, New England Journal of Medicine	2014	1.7K
Ledipasvir and Sofosbuvir for Previously Treated HCV Genotype 1 Infection Nezam H. Afdhal, K. Rajender Reddy, David R. Nelson, New England Journal of Medicine	2014	1.3K
Sofosbuvir and Velpatasvir for HCV Genotype 2 and 3 Infection Graham R. Foster, Nezam H. Afdhal, Stuart K. Roberts, New England Journal of Medicine	2015	845
Ledipasvir and Sofosbuvir Plus Ribavirin for Treatment of HCV Infection in Patients With Advanced Liver Disease Michael Charlton, Gregory T. Everson, Steven L. Flamm, Gastroenterology	2015	795
Response-Guided Telaprevir Combination Treatment for Hepatitis C Virus Infection Kenneth E. Sherman, Steven L. Flamm, Nezam H. Afdhal, New England Journal of Medicine	2011	744
Interleukin-28B Polymorphism Improves Viral Kinetics and Is the Strongest Pretreatment Predictor of Sustained Virologic Response in Genotype 1 Hepatitis C Virus Alexander Thompson, Andrew J. Muir, Mark S. Sulkowski, Gastroenterology Viral PersistenceHepatologyHepatitis CViral KineticsViral Hepatitis	2010	723
Telaprevir for Previously Treated Chronic HCV Infection John G. McHutchison, Michael P. Manns, Andrew J. Muir, New England Journal of Medicine	2010	719
The ASK1 inhibitor selonsertib in patients with nonalcoholic steatohepatitis: A randomized, phase 2 trial Rohit Loomba, Eric Lawitz, Parvez Mantry, Hepatology Collagen ContentPathologyCell DeathPharmacotherapyFatty Liver Disease	2017	541
Peginterferon and Ribavirin Treatment in African American and Caucasian American Patients With Hepatitis C Genotype 1 Hari S. Conjeevaram, Michael Fried, Lennox J. Jeffers, Gastroenterology Caucasian American PatientsHepatologyHepatitis CAfrican AmericanViral Hepatitis	2006	473

Page 1